Venlafaxine
Axyven contains the active substance venlafaxine. Axyven is an antidepressant that belongs to a group of medicines called serotonin and noradrenaline reuptake inhibitors (SNRIs). This group of medicines is used to treat depression and other conditions such as anxiety disorders. The mechanism of action of antidepressants is not fully understood, but they may help by increasing the levels of serotonin and noradrenaline in the brain. Axyven is used to treat adult patients with depression. Axyven is also indicated for the treatment of the following anxiety disorders in adult patients: generalized anxiety disorder, social anxiety disorder (fear or avoidance of social situations), and panic disorder (panic attacks). It is important for the patient's well-being that the treatment of depression and anxiety disorders is carried out properly. If the patient does not undergo treatment, their condition may not improve, may worsen, and may become more difficult to treat.
Side effects can also occur when you stop taking IMAO medicines and start taking Axyven (see also "Axyven with other medicines" and "Serotonin syndrome").
Before startingtreatment with Axyven, you should discuss it with your doctor or pharmacist:
During the first few weeks of treatment with Axyven, you may experience restlessness or an inability to sit or stand still. If such symptoms occur, you should inform your doctor. Do not drink alcohol during treatment with Axyven, as it may cause extreme fatigue and loss of consciousness. Taking Axyven with alcohol and/or certain other medicines may increase the severity of depression and other conditions, such as anxiety disorders. Suicidal thoughts and worsening of depression or anxiety disorders Patients with depression and/or anxiety disorders may sometimes have thoughts of self-harm or suicide. Such thoughts or behavior may worsen at the beginning of treatment with antidepressants, as these medicines usually start working after two weeks or sometimes later. These thoughts may also occur after reducing the dose or during discontinuation of Axyven. Such thinking may be more likely if:
If you experience suicidal thoughts or thoughts of self-harm, you should immediately contact your doctor or go to the emergency department of the nearest hospital. It may be helpful to inform your relatives or friends about your depression or anxiety disorder and ask them to read this leaflet. You can ask your relatives or friends to help you and ask them to inform you if they notice that your depression or anxiety has worsened or if you have made any disturbing changes in your behavior. Dry mouth Dry mouth was reported by 10% of patients treated with venlafaxine. This may increase the risk of tooth decay. Therefore, you should take special care of your oral hygiene. Patients with diabetes The level of glucose in your blood may change when taking Axyven. Therefore, the dosage of your antidiabetic medicines may need to be adjusted. Sexual dysfunction Medicines like Axyven (so-called SSRIs or SNRIs) may cause sexual dysfunction (see section 4). In some cases, these symptoms have persisted after discontinuation of treatment.
Axyven should not normally be used in children and adolescents under 18 years of age. It should also be known that in the case of taking this class of medicines, patients under 18 years of age are at increased risk of side effects such as suicidal attempts, suicidal thoughts, and hostility (especially aggression, rebellious behavior, and manifestations of anger). Despite this, your doctor may prescribe this medicine to patients under 18 years of age if they consider it to be in their best interest. If your doctor has prescribed this medicine to a patient under 18 years of age and you have any doubts, you should consult your doctor. You should inform your doctor if any of the following symptoms occur or worsen in patients under 18 years of age taking Axyven. Additionally, as yet, there are no long-term data on the safety of this medicine in this age group regarding the effects on growth, maturation, and cognitive and behavioral development.
Tell your doctor or pharmacist about all the medicines you are taking now or have taken recently, as well as any medicines you plan to take. Your doctor will decide whether to use Axyven with other medicines. Do not start or stop taking other medicines, including those available without a prescription, herbal, or natural remedies, without consulting your doctor or pharmacist first.
Examples of such medicines include:
Subjective and objective symptoms of serotonin syndrome may include a combination of the following symptoms: restlessness, hallucinations, loss of coordination, accelerated heart rate, elevated body temperature, rapid changes in blood pressure, hyperactivity, diarrhea, coma, nausea, vomiting. In its most severe form, serotonin syndrome can resemble neuroleptic malignant syndrome. Objective and subjective symptoms may include a combination of fever, accelerated heart rate, sweating, severe muscle stiffness, disorientation, and increased levels of muscle enzymes (measured in a blood test).
If you are taking medicines that may affect your heart rhythm, you should inform your doctor. Examples of such medicines include:
The following medicines may also interact with Axyven and should be used with caution. It is especially important to inform your doctor or pharmacist if you are taking medicines containing:
Axyven should be taken with food (see section 3, "How to take Axyven"). Do not drink alcohol during treatment with Axyven. Taking Axyven with alcohol may cause extreme fatigue and loss of consciousness, as well as worsen symptoms of depression and other conditions, such as anxiety disorders.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, ask your doctor for advice before taking this medicine. You should only take Axyven after discussing the potential benefits and risks with your doctor. Make sure your doctor and/or midwife know that you are taking Axyven. Taking similar medicines (SSRIs) during pregnancy may increase the risk of serious complications in the newborn, called persistent pulmonary hypertension of the newborn (PPHN), which is characterized by rapid breathing and bluish discoloration. These symptoms usually occur within the first 24 hours after birth. If such symptoms occur in the newborn, you should immediately contact your doctor and/or midwife. Taking Axyven at the end of pregnancy may increase the risk of severe vaginal bleeding shortly after delivery, especially if you have a history of bleeding disorders. If you are taking Axyven, you should inform your doctor or midwife so that they can provide you with appropriate advice. If you are taking this medicine during pregnancy, your baby may experience, in addition to breathing difficulties, other symptoms such as sucking problems after birth. If you are concerned about such symptoms in your newborn after birth, you should contact your doctor and/or midwife, who will be able to provide you with proper advice. Axyven passes into breast milk. There is a risk of an effect on the baby. You should discuss this with your doctor, and your doctor will decide whether to stop breastfeeding or stop treatment with this medicine.
Do not drive or operate any tools or machines until you know how Axyven affects you.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist. The usual recommended starting dose for depression, generalized anxiety disorder, social anxiety disorder is 75 mg once daily. This dose may be gradually increased by your doctor if necessary up to a maximum dose of 375 mg once daily for depression. For panic disorder, treatment should start with a dose of 37.5 mg once daily, which may be gradually increased. The maximum dose for generalized anxiety disorder, social anxiety disorder, and panic disorder is 225 mg once daily. Axyven should be taken once daily at approximately the same time, regardless of whether you take it in the morning or evening. The tablets should be swallowed whole with a drink of water and should not be divided, crushed, chewed, or dissolved. Axyven should be taken with food (see section 2, "Important information before taking Axyven"). If you have liver or kidney problems, you should inform your doctor, as you may need a dose adjustment. Do not stop taking Axyven without consulting your doctor (see section "Stopping treatment with Axyven").
If you have taken more Axyven than you should, you should immediately contact your doctor or pharmacist. Overdose can be life-threatening, especially when taken with alcohol and/or certain other medicines (see "Axyven with other medicines"). Symptoms of possible overdose may include accelerated heart rate, disturbances of consciousness (from drowsiness to coma), visual disturbances, seizures or convulsions, and vomiting.
If you forget to take a dose, you should take it as soon as possible. However, if it is almost time for your next dose, you should skip the missed dose and take only one dose at the usual time. Do not take a double dose to make up for a missed dose. Do not take more than the prescribed daily dose of Axyven.
Do not stop taking Axyven without consulting your doctor, even if you feel better. If your doctor decides that you can stop taking Axyven, they will tell you how to gradually reduce the dose before completely stopping treatment. When stopping treatment with Axyven, especially when stopping suddenly or reducing the dose too quickly, you may experience side effects. Some patients may experience symptoms such as suicidal thoughts, aggression, fatigue, dizziness, headache, insomnia, nightmares, dry mouth, loss of appetite, nausea, diarrhea, nervousness, agitation, disorientation, ringing in the ears, tingling or rarely electric shock sensation, weakness, sweating, seizures, or flu-like symptoms, and increased blood pressure (which can cause headaches, dizziness, ringing in the ears, sweating, etc.). Your doctor will advise you on how to gradually stop taking Axyven. This may take several weeks or months. In some patients, it may be necessary to stop the medicine very gradually over several months or longer. If you experience any of these symptoms or other symptoms that are troublesome to you, you should consult your doctor. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Axyven can cause side effects, although not everybody gets them. If you experience any of the following side effects, you should stop taking Axyven and immediately contact your doctor or go to the emergency department of the nearest hospital.
Other side effects that you should tell your doctor about(the frequency of these side effects is given below in the section "Other side effects") include:
Absorbed.
Axyven may sometimes cause side effects that you may not be aware of, such as increased blood pressure or abnormal heart rhythm, mild changes in liver enzyme activity, sodium or cholesterol levels in the blood. More rarely, Axyven may cause bleeding disorders, which increase the risk of bruising or bleeding. Therefore, your doctor may recommend that you have a blood test from time to time, especially if you are taking Axyven for a long time.
If you experience any side effects, including those not listed in this leaflet, you should inform your doctor or pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: 22 49-21-301, fax: 22 49-21-309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the packaging after EXP. The expiry date refers to the last day of that month. There are no special storage instructions for this medicine. Blister packs: store in the original package to protect from moisture. HDPE bottle: store the bottle tightly closed to protect from moisture. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Each prolonged-release tablet contains 37.5 mg, 75 mg, or 150 mg of venlafaxine (as hydrochloride). The other ingredients are: Core: mannitol (E 421), povidone K 90, macrogol 400, microcrystalline cellulose (E 460(i)), silicon dioxide, anhydrous, magnesium stearate (E 470b). Coating: cellulose acetate (320S NF), cellulose acetate (398-10NF), macrogol 400, Opadry White Y-30-18037 (hypromellose, lactose monohydrate, titanium dioxide (E 171), triacetin).
37.5 mg: round, 7 mm in diameter, biconvex, white prolonged-release tablets. 75 mg: round, 7.5 mm in diameter, biconvex, white prolonged-release tablets. 150 mg: round, 9.5 mm in diameter, biconvex, white prolonged-release tablets. Axyven is available in blister packs of 28 and 30 prolonged-release tablets and in plastic bottles containing 100 prolonged-release tablets. Not all pack sizes may be marketed.
Exeltis Poland Sp. z o.o. ul. Szamocka 8 01-748 Warsaw
Laboratorios LICONSA, S.A. Avda. Miralcampo no 7 Poligono Industrial Miralcampo 19200 Azuqueca de Henares Spain
Sweden Venlafaxin 1A Farma 37.5/75/150/225 mg prolonged-release tablets Estonia Venlafaxine Wörwag Pharma 37.5/75/150/225 mg prolonged-release tablets Greece SEROSMINE 37.5/75/150/225 mg prolonged-release tablets France VENLAFAXINE BIPHAR 150/225 mg prolonged-release tablets Italy Zarelis 37.5/75/150/225 mg prolonged-release tablets Netherlands Venlafaxine Aurobindo 225 mg prolonged-release tablets Poland Axyven, 37.5/75/150 mg, prolonged-release tablets Portugal Zarelix 37.5/75/150/225 mg prolonged-release tablets United Kingdom Venlafaxine XL 37.5/75/150/225 mg prolonged-release tablets Date of last revision of the leaflet:25.02.2025
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.